As filed with the Securities and Exchange Commission on June 20, 2024
Registration No. 333-238866
Registration No. 333-265901
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Post-Effective Amendment No. 1 to:
Form S-8 Registration Statement No. 333-238866
Form S-8 Registration Statement No. 333-265901
UNDER
THE SECURITIES ACT OF 1933
TRANSPHORM, INC.
(Exact name of Registrant as specified in its charter)
Delaware | 82-1858829 | |
(State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification Number) |
75 Castilian Drive Goleta, California 93117
(Address of principal executive offices, including zip code)
2007 Stock Plan
2015 Equity Incentive Plan
2020 Equity Incentive Plan
(Full title of the plans)
Primit Parikh
President and Chief Executive Officer
Transphorm, Inc.
75 Castilian Drive
Goleta, California 93117
(805) 456-1300
(Name, address, including zip code, and telephone number, including area code, of agent for service)
Copies to:
Erika Muhl
Wilson Sonsini Goodrich & Rosati,
Professional Corporation
650 Page Mill Road
Palo Alto, California 94304
(650) 493-9300
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of large accelerated filer, accelerated filer, smaller reporting company and emerging growth company in Rule 12b-2 of the Exchange Act.
Large accelerated filer | ☐ | Accelerated filer | ☐ | |||
Non-accelerated filer | ☒ | Smaller reporting company | ☒ | |||
Emerging growth company | ☒ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐
DEREGISTRATION OF UNSOLD SECURITIES
These post-effective amendments (the Post-Effective Amendments) relate to the following Registration Statements on Form S-8 (collectively, the Registration Statements), previously filed with the Securities and Exchange Commission by Transphorm, Inc. (the Company), each pertaining to the registration of shares of the Registrants common stock, $0.0001 par value (the Common Stock) offered under certain employee benefit and equity plans and agreements:
File No. |
Date Filed |
Name of Equity Plan or Agreement |
Shares of Common Stock (#) | |||
333-238866 |
June 2, 2020 | 5,050,000 | ||||
333-265901 |
June 29, 2022 | 2020 Equity Incentive Plan | 4,695,564 |
On June 20, 2024, pursuant to that certain Agreement and Plan of Merger (the Merger Agreement), dated as of January 10, 2024, by and among Renesas Electronics America Inc., a California corporation (Parent), Travis Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (Merger Sub), Renesas Electronics Corporation, a Japanese corporation (solely for the purposes set forth in Section 9.17 of the Merger Agreement), and the Company, Merger Sub merged with and into the Company, with the Company continuing as the surviving corporation and a wholly owned subsidiary of Parent (the Merger).
As a result of the Merger, the Company has terminated all offerings of its securities pursuant to the Registration Statements. The Company hereby terminates the effectiveness of the Registration Statements and, in accordance with undertakings made by the Company in the Registration Statements to remove from registration by means of a post-effective amendment any of the securities that had been registered but which remain unsold at the termination of the offering, hereby removes from registration any and all securities registered under the Registration Statements that remain unsold or otherwise unissued as of the date hereof.
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, as amended, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused these Post-Effective Amendments to the Registration Statements to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Goleta, State of California, on June 20, 2024.
TRANSPHORM, INC. | ||
By: | /s/ Primit Parikh | |
Primit Parikh | ||
President and Chief Executive Officer |
Pursuant to Rule 478 under the Securities Act of 1933, as amended, no other person is required to sign these Post-Effective Amendments.